flow trial semaglutide kidney outcomes 2024 nejm hazard ratio in Patients with Obesity-Related Heart Failure and Type 2 Diabetes 🚨 Journal Club: FLOW Trial

Hypoglycemia and Diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society

It's a tool that must be integrated into a holistic approach encompassing lifestyle changes, regular monitoring, and open communication with your healthcare provider to achieve and maintain positive health outcomes.

Hypoglycemia risk in non-diabetics: This appears to remain low with retatrutide, but glucagon's role in glucose regulation warrants close monitoring

Rare but serious side effects should be discussed with your provider

In this episode, we discuss the definitions of high, normal, low, and ultra-low LDL-C, what functional assays are used to measure LDL-C, and what is considered the safe lower-limit of LDL-C, if there is one at all

For full details on timing, dose increases, and guidance, see our Wegovy dosing schedule and dosage chart